A
Menu
First published November 16, 2023 Application Aachen patent A – Human necessities

IMMUNOTHERAPEUTIC COMPOSITIONS AND ADJUVANTS

Espacenet Family 83080774

Abstract

The present invention provides compositions for modulating an immune response in a subject. The compositions include micelles formed from elastin-like peptides (ELPs) that may be bound to immunomodulators. The invention also provides uses of such micelles as adjuvants. Also provided are pharmaceutical formulations including the compositions for use as medicaments, particularly for use in treating cancers, allergy and infectious disease.

Inventors 7

  1. Alexander Kros Aachen author as filed: Kros, Alexander
  2. René C. L. Olsthoorn Aachen author as filed: Olsthoorn, René
  3. Jolinde van Strien Aachen author as filed: van Strien, Jolinde
  4. Romain Leboux Aachen author as filed: Leboux, Romain
  5. van Ree, Ronald
  6. Hans Warmenhoven Aachen author as filed: Warmenhoven, Hans
  7. Wim Jiskoot Aachen author as filed: Jiskoot, Wim

Inventors are linked to an Aachen author when surname and first name match exactly one author.

Applicants

  • UNIVERSITEIT LEIDEN GBS Leiden
  • ACADEMISCH MEDISCH CENTRUM
  • Acad Medisch Ct

Cited papers 25 in the database

Non-patent literature as cited (113)
  • - S. R. MACEWAN ET AL., BIOPOLYMERS, vol. 94, no. 1, 2010, pages 60 - 77
  • - A. CHILKOTI ET AL., ADVANCED DRUG DELIVERY REVIEWS, vol. 54, 2002, pages 1093 - 1111
  • - MACEWAN S R ET AL., BIOPOLYMERS, vol. 94, no. 1, pages 60 - 77
  • - NILSSON ET AL., ANN REV BIOPHYS BIO STRUCTURE, vol. 34, 2005, pages 91 - 118
  • - KOLBFINN, SHARPLESS ANGEWANDTE CHEMIE INTERNATIONAL EDITION, vol. 40, 2001, pages 2004 - 2021
  • - EVANS, AUSTRALIAN JOURNAL OF CHEMISTRY, vol. 60, 2007, pages 384 - 395
  • - KOLB, H. C.FINN, M. G.SHARPLESS, K. B., ANGEW. CHEM. INT., vol. 40, 2001, pages 2004 - 2021
  • - KOLB, H. C.SHARLESS, K. B., DRUG DISC. TODAY, vol. 8, 2003, pages 112 - 1137
  • - GREEN L. G.FOKIN, V. V.SHRAPLESS, K. B., ANGEW. CHEM. INT. ED., vol. 41, 2002, pages 1053 - 41057
  • - TOMOE, C. W.CHRISTENSEN, C.MELDAL, M., J. ORG. CHEM., vol. 67, 2002, pages 3057 - 3064
  • - LEE, L. V. ET AL., J. AM. CHEM. SOC., vol. 125, 2003, pages 9588 - 9589
  • - MANETSCH, R. ET AL., J. AM. CHEM. SOC., vol. 126, 2004, pages 12809 - 12818
  • - MOCHARLA, V. P. ET AL., ANGEW. CHEM., INT. ED., vol. 44, 2005, pages 116 - 120
  • - HAUGLAND, RICHARD P.: "MOLECULAR PROBESTM Handbook", 1996, article "Guide to Fluorescent Probes and Labeling Technologies"
  • - GEYSEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 8, 1984, pages 3998 - 4002
  • - GEYSEN ET AL., PROC. NATL. ACAD. SCI. USA, vol. 82, 1985, pages 78 - 182
  • - GEYSEN ET AL., MOL. IMMUNOL., vol. 23, 1986, pages 709 - 715
  • - HOPP ET AL., PROC. NATL. ACAD. SCI USA, vol. 78, 1981, pages 3824 - 3828
  • - KYTE ET AL., J. MOL. BIOL., vol. 157, 1982, pages 105 - 132
  • - "UniProt", Database accession no. 018874
  • - GADERMAIER G ET AL., CURR ALLERGY ASTHMA REP., vol. 4, no. 5, 2004, pages 391 - 400
  • - ROUSSEL ET AL., BIOCHIMIE, vol. 70, 1988, pages 1471
  • - BURCHELL ET AL., CANCER RES., vol. 47, 1987, pages 5476
  • - JEROME ET AL., CANCER RES., vol. 51, 1991, pages 2908
  • - MASON J.M.ARNDT K.M.: "Coiled coil domains: Stability, specificity, and biological implications", CHEMBIOCHEM, vol. 5, 2004, pages 170 - 176, XP072141959, DOI: 10.1002/cbic.200300781
  • - LUPAS A.N.GRUBER M.: "The structure of a-helical coiled coils", ADV. PROTEIN CHEM., vol. 70, 2005, pages 37 - 38
  • - WOOLFSON D.N.BARTLETT G.J.BRUNING M.THOMSON A.R.: "New currency for old rope: From coiled-coil assemblies to a-helical barrels", CURR. OPIN. STRUCT. BIOL., vol. 22, 2012, pages 432 - 441
  • - APOSTOLOVIC B.DANIAL M.KLOK H.-A.: "Coiled coils: Attractive protein folding motifs for the fabrication of self-assembled, responsive and bioactive materials", CHEM. SOC. REV., vol. 39, 2010, pages 3541 - 3575
  • - G., KEATING A.E.: "Structural specificity in coiled-coil interactions", CURR. OPIN. STRUCT. BIOL., vol. 18, 2008, pages 477 - 483, XP023979204, DOI: 10.1016/j.sbi.2008.04.008
  • - LAPENTA, FABIO ET AL.: "Coiled coil protein origami: from modular design principles towards biotechnological applications", CHEMICAL SOCIETY REVIEWS, vol. 47, no. 10, 2018, pages 3530 - 3542
  • - AKKERDAAS, J. H.REE, R.AALBERS, M.STAPEL, S. O.AALBERSE, R. C.: "Multiplicity of cross-reactive epitopes on Bet v 1 as detected with monoclonal antibodies and human IgE", ALLERGY, vol. 50, 1995, pages 215 - 220, XP009079725
  • - TAL, M.SILBERSTEIN, A.NUSSER, E.: "Why does Coomassie Brilliant Blue R interact differently with different proteins? A partial answer", J. BIOL. CHEM., vol. 260, 1985, pages 9976 - 9980
  • - SINGLETONSAINSBURY: "Dictionary of Microbiology and Molecular Biology", 1994, JOHN WILEY AND SONS
  • - HALEMARHAM: "The Harper Collins Dictionary of Biology", HARPER PERENNIAL, 1991
  • - ORENSTEIN, W. A.AHMED, R.: "Simply put: Vaccination saves lives", PNAS, vol. 114, 2017, pages 4031 - 4033
  • - CAO, Y.ZHU, X.KAKAR, P.ZHAO, Y.CHEN, X.: "Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant", NAT. COMMUN., vol. 9, 2018, pages 1 - 13
  • - ZHANG, R. ET AL.: "Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity", AAPS J., vol. 20, no. 73, 2018
  • - ZHAO, Z.UKIDVE, A.KRISHNAN, V.MITRAGOTRI, S.: "Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers", ADV. DRUG DELIV. REV., vol. 143, 2019, pages 3 - 21, XP085812346, DOI: 10.1016/j.addr.2019.01.002
  • - HOGENESCH, H.: "Mechanism of immunopotentiation and safety of aluminum adjuvants", FRONT. IMMUNOL., vol. 3, 2013, pages 1 - 13
  • - VOGELBRUCH, B.NUSS, B.KORNER, M.KAPP, A.KIEHL, P.: "Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations", ALLERGY, vol. 55, 2000, pages 883 - 887
  • - GREGORY, A. E.TITBALL, R.WILLIAMSON, D.: "Vaccine delivery using nanoparticles", FRONT. CELL. INFECT. MICROBIOL., vol. 3, 2013, pages 1 - 13
  • - KYUNG, M.KIM, J.: "Properties of immature and mature dendritic cells: Phenotype, morphology, phagocytosis, and migration", RSCADV., vol. 9, 2019, pages 11230 - 11238, XP055845444, DOI: 10.1039/C9RA00818G
  • - SUN, B.XIA, T.: "Nanomaterial-based vaccine adjuvants", J MATER CHEM B., vol. 33, 2016, pages 5496 - 5509
  • - KAECH, S. M.WHERRY, E. J.AHMED, R.: "Effector and memory T-cell differentiation: Implications for vaccine development", NAT. REV., vol. 2, 2002, pages 251 - 262, XP037115090, DOI: 10.1038/nri778
  • - BENNE, N., VAN DUIJN, J., KUIPER, J., JISKOOT, W. & STUTTER, B.: "Orchestrating immune responses: How size, shape and rigidity affect the immunogenicity of particulate vaccines", J. CONTROL. RELEASE, vol. 234, 2016, pages 124 - 134, XP029616181, DOI: 10.1016/j.jconrel.2016.05.033
  • - SLUTTER, B. ET AL.: "Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen", J. CONTROL. RELEASE, vol. 143, 2010, pages 207 - 214
  • - SLUTTER, B. ET AL.: "Antigen-adjuvant nanoconjugates for nasal vaccination: An improvement over the use of nanoparticles?", MOL. PHARM., vol. 7, 2010, pages 2207 - 2215, XP055308450, DOI: 10.1021/mp100210g
  • - WANG, Z.XU, J.: "Better adjuvants for better vaccines: Progress in adjuvant delivery systems, modifications, and adjuvant-antigen codelivery", VACCINES, vol. 8, 2020, pages 1 - 20
  • - NI, Q. ET AL.: "A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer", SCI. ADV., vol. 6, 2020, pages 1 - 12
  • - BARNIER QUER, C. ET AL.: "Polymersomes enhance the immunogenicity of influenza subunit vaccine", POLYM. CHEM., vol. 2, 2011, pages 1482 - 1485
  • - ZOPE, H. ET AL.: "Peptide amphiphile nanoparticles enhance the immune response against a CpG-adjuvanted influenza antigen", ADV. HEALTHC. MATER., vol. 3, 2014, pages 343 - 348
  • - APOSTOLOVIC, B.DEACON, S. P. E.DUNCAN, R.KLOK, H. A.: "Cell uptake and trafficking behavior of non-covalent, coiled-coil based polymer-drug conjugates", MACROMOL. RAPID COMMUN., vol. 32, 2011, pages 11 - 18
  • - DHANKHER, A.LV, W.STUDSTILL, W. T.CHAMPION, J. A.: "Coiled coil exposure and histidine tags drive function of an intracellular protein drug carrier", J. CONTROL. RELEASE, vol. 339, 2021, pages 248 - 258, XP086861267, DOI: 10.1016/j.jconrel.2021.09.026
  • - ASGARI, S.SCHMIDT, O.: "A coiled-coil region of an insect immune suppressor protein is involved in binding and uptake by hemocytes", INSECT BIOCHEM. MOL. BIOL., vol. 32, 2002, pages 497 - 504, XP027389104
  • - KNODLER, L. A.IBARRA, J. A.PEREZ-RUEDA, E.YIP, C. K.STEELE-MORTIMER, O.: "Coiled-coil domains enhance the membrane association of Salmonella type III effectors", CELL. MICROBIOL., vol. 13, 2011, pages 1497 - 1517
  • - BODE, S. A. ET AL.: "Coiled-coil-mediated activation of oligoarginine cell-penetrating peptides", CHEMBIOCHEM COMMUN, vol. 18, 2017, pages 185 - 188
  • - SEGREST, J. P.LOOF, H.DOHLMAN, J. G.BROUILLETTE, C. G.ANANTHARAMAIAH, G. M.: "Amphipathic helix motif: Classes and properties", PROTEINS STRUCT. FUNCT. GENET., vol. 8, 1990, pages 103 - 117, XP000770511, DOI: 10.1002/prot.340080202
  • - RABE, M.SCHWIEGER, C.ZOPE, H. R.VERSLUIS, F.KROS, A.: "Membrane interactions of fusogenic coiled-coil peptides: Implications for lipopeptide mediated vesicle fusion", LANGMUIR, vol. 30, 2014, pages 7724 - 7735
  • - HANSEN, M.KILK, K.LANGEL, U.: "Predicting cell-penetrating peptides", ADV. DRUG DELIV. REV., vol. 60, 2008, pages 572 - 579, XP022476847, DOI: 10.1016/j.addr.2007.09.003
  • - MCKENZIE, E. J.MUKHOPADHYAY, S.GORDON, S.MARTINEZ-POMARES, L.: "Handbook of Dendritic Cells: Biology, Diseases, and Therapies", 2006, article "Scavenger Receptors on Dendritic Cells", pages: 141 - 163
  • - KRAMER, K.SHIELDS, N. J.POPPE, V.YOUNG, S. L.WALKER, G. F.: "Intracellular cleavable CpG oligodeoxynucleotide-antigen conjugate enhances anti-tumor immunity", MOL. THER., vol. 25, 2017, pages 62 - 70, XP055613007, DOI: 10.1016/j.ymthe.2016.10.001
  • - WU, Y.COLLIER, J. H: "a-Helical coiled-coil peptide materials for biomedical applications", WILEY INTERDISCIP. REV. NANOMEDICINE NANOBIOTECHNOLOGY, vol. 9, 2017, pages 1 - 33
  • - CRONE, N. S. A.KROS, A.BOYLE, A. L.: "Modulation of coiled-coil binding strength and fusogenicity through peptide stapling", BIOCONJUG. CHEM., vol. 31, 2020, pages 834 - 843
  • - JANIB, S. M. ET AL.: "A quantitative recipe for engineering protein polymer nanoparticles", POLYM. CHEM., vol. 5, 2014, pages 1614 - 1625
  • - PILLE, J.VAN LITH, S. A. M.VAN HEST, J. C. M.LEENDERS, W. P. J.: "Self-assembling VHH-elastin-like peptides for photodynamic nanomedicine", BIOMACROMOLECULES, vol. 18, 2017, pages 1302 - 1310, XP055815275, DOI: 10.1021/acs.biomac.7b00064
  • - DOMINGOS, R. F.: "Characterizing manufactured nanoparticles in the environment: Multimethod determination of particle sizes", ENVIRON. SCI. TECHNOL., vol. 43, 2009, pages 7277 - 7284, XP055409849, DOI: 10.1021/es900249m
  • - LEBOUX, R. J. T. ET AL.: "High-affinity antigen association to cationic liposomes via coiled coil-forming peptides induces a strong antigen-specific CD4+ T-cell response", EUR. J. PHARM. BIOPHARM., vol. 158, 2021, pages 96 - 105, XP086463977, DOI: 10.1016/j.ejpb.2020.11.005
  • - NACE, G.EVANKOVICH, J.EID, R.TSUNG, A.: "Dendritic cells and damage-associated molecular patterns: Endogenous danger signals linking innate and adaptive immunity", J. INNATE IMMUN., vol. 4, 2011, pages 6 - 15
  • - BENNE, N. ET AL.: "Anionic 1 ,2-distearoyl-sn-glycero-3-phosphoglycerol (DSPG) liposomes induce antigen-specific regulatory T cells and prevent atherosclerosis in mice", J. CONTROL. RELEASE, vol. 291, 2018, pages 135 - 146, XP085533482, DOI: 10.1016/j.jconrel.2018.10.028
  • - KEIJZER, C. ET AL.: "PLGA, PLGA-TMC and TMC-TPP nanoparticles differentially modulate the outcome of nasal vaccination by inducing tolerance or enhancing humoral immunity", PLOS ONE 6, 2011, pages 1 - 10
  • - BRITO, L. A.SINGH, M.: "Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical Research", J. PHARM. SCI., vol. 100, 2011, pages 34 - 37
  • - FINEGOLD, I. ET AL.: "Immunotherapy throughout the decades: From Noon to now", ANN. ALLERGY, ASTHMA IMMUNOL., vol. 105, 2010, pages 328 - 336, XP027461285, DOI: 10.1016/j.anai.2010.08.008
  • - DHAMI, S. ET AL.: "Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis", ALLERGY EUR. J. ALLERGY CLIN. IMMUNOL., vol. 72, 2017, pages 1825 - 1848
  • - MOBS, C. ET AL.: "Birch pollen immunotherapy results in long-term loss of Bet v 1-specific Th2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies", J. ALLERGY CLIN. IMMUNOL., vol. 130, 2012, pages 1108 - 1116
  • - FLICKER, S.VALENTA, R.: "Renaissance of the blocking antibody concept in type I allergy", INT. ARCH. ALLERGY IMMUNOL., vol. 132, 2003, pages 13 - 24, XP009150393, DOI: 10.1159/000073260
  • - VRTALA, S. ET AL.: "Immunization with purified natural and recombinant allergens induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation", J IMMUNOL, vol. 160, 1998, pages 6137 - 6144
  • - AKDIS, C. A.AKDIS, M.: "Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens", WORLD ALLERGY ORGAN. J., vol. 8, 2015, pages 1 - 12
  • - SHAMJI, M. H.DURHAM, S. R.: "Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers", J ALLERGY CLIN IMMUNOL, vol. 140, 2017, pages 1485 - 1498, XP085290787, DOI: 10.1016/j.jaci.2017.10.010
  • - VALENTA, R. ET AL.: "Allergen extracts for in vivo diagnosis and treatment of allergy: Is there a future?", J. ALLERGY CLIN. IMMUNOL. PRACT., vol. 6, 2018, pages 1845 - 1855
  • - PAULI, G. ET AL.: "Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis", J. ALLERGY CLIN. IMMUNOL., vol. 122, 2008, pages 951 - 960, XP025641314, DOI: 10.1016/j.jaci.2008.09.017
  • - ZABORSKY, N. ET AL.: "Antigen Aggregation Decides the Fate of the Allergic Immune Response", J. IMMUNOL., vol. 184, 2010, pages 725 - 735
  • - WALGRAFFE, D. ET AL.: "A hypoallergenic variant of Der p 1 as a candidate for mite allergy vaccines", J. ALLERGY CLIN. IMMUNOL., vol. 123, 2009, pages 1150 - 1156, XP026083378, DOI: 10.1016/j.jaci.2008.11.038
  • - HAKA, J. ET AL.: "Development of hypoallergenic variants of the major horse allergen Equ c 1 for immunotherapy by rational structure based engineering", SCI. REP., vol. 9, 2019, pages 1 - 11
  • - HE, P.ZOU, Y.HU, Z.: "Advances in aluminum hydroxide-based adjuvant research and its mechanism", HUM. VACCINES IMMUNOTHER, vol. 11, 2015, pages 477 - 488, XP055257285, DOI: 10.1080/21645515.2014.1004026
  • - JOUBERT, A. I. ET AL.: "Mechanisms of particles in sensitization, effector function and therapy of allergic disease", FRONT. IMMUNOL., vol. 11, 2020, pages 1 - 20
  • - DE GREGORIO, E.TRITTO, E.RAPPUOLI, R.: "Alum adjuvanticity: Unraveling a century old mystery", EUR. J. IMMUNOL., vol. 38, 2008, pages 2068 - 2071, XP071223758, DOI: 10.1002/eji.200838648
  • - EXLEY, C.: "Aluminium adjuvants and adverse events in subcutaneous allergy immunotherapy", ALLERGY, ASTHMA CLIN. IMMUNOL., vol. 10, 2014, pages 1 - 5
  • - CORKINS, M. R.: "Aluminum effects in infants and children", PEDIATRICS, vol. 144, 2019, pages 1 - 9
  • - TOMLJENOVIC, L.A. SHAW: "C. Aluminum vaccine adjuvants: Are they safe?", CURR. MED. CHEM., vol. 18, 2011, pages 2630 - 2637
  • - JOHNSTON, C. T.WANG, S. L.HEM, S. L.: "Measuring the surface area of aluminum hydroxide adjuvant", J. PHARM. SCI., vol. 91, 2002, pages 1702 - 1706, XP055030004, DOI: 10.1002/jps.10166
  • - KLEIJ, H. P. M. ET AL.: "Chemically modified peanut extract shows increased safety while maintaining immunogenicity", ALLERGY EUR. J. ALLERGY CLIN. IMMUNOL., vol. 74, 2019, pages 986 - 995, XP071463516, DOI: 10.1111/all.13687
  • - MANOLOVA, V. ET AL.: "Nanoparticles target distinct dendritic cell populations according to their size", EUR. J. IMMUNOL, vol. 38, 2008, pages 1404 - 1413, XP002562517, DOI: 10.1002/eji.200737984
  • - SOUZA REBOUGAS, J. ET AL.: "Nanoparticulate adjuvants and delivery systems for allergen immunotherapy", J. BIOMED. BIOTECHNOL. 2012, 2012, pages 1 - 13, XP055390880, DOI: 10.1155/2012/474605
  • - MOHAPATRA, S. S., QAZI, M. & HELLERMANN, G.: "Immunotherapy for allergies and asthma: Present and future", CURR. OPIN. PHARMACOL., vol. 10, 2010, pages 276 - 288, XP027137702
  • - WAI, C. Y. Y., LEUNG, N. Y. H., LEUNG, P. S. C. & CHU, K. H.: "Immunotherapy of food allergy: A comprehensive review", CLIN. REV. ALLERGY IMMUNOL., vol. 57, 2019, pages 55 - 73, XP036834619, DOI: 10.1007/s12016-017-8647-y
  • - GOMORD, V. ET AL.: "Design, production and immunomodulatory potency of a novel allergen bioparticle", PLOS ONE, vol. 15, 2020, pages 1 - 27
  • - VOGEL, L.LUTTKOPF, D.HATAHET, L.HAUSTEIN, D.VIETHS, S.: "Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system", ALLERGY EUR. J. ALLERGY CLIN. IMMUNOL., vol. 60, 2005, pages 1021 - 1028, XP071459643, DOI: 10.1111/j.1398-9995.2005.00803.x
  • - SOH, W. T. ET AL.: "Multiple roles of Bet v 1 ligands in allergen stabilization and modulation of endosomal protease activity", ALLERGY EUR. J. ALLERGY CLIN. IMMUNOL., vol. 74, 2019, pages 2382 - 2393, XP071463535, DOI: 10.1111/all.13948
  • - ENGEROFF, P. ET AL.: "Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells", ALLERGY EUR. J. ALLERGY CLIN. IMMUNOL., vol. 73, 2018, pages 341 - 349
  • - WALLNER, M. ET AL.: "Reshaping the Bet v 1 fold modulates TH polarization", J. ALLERGY CLIN. IMMUNOL., vol. 127, 2011, pages 1571 - 1578
  • - PICHLER, U. ET AL.: "The fold variant BM4 is beneficial in a therapeutic bet v 1 mouse model", BIOMED RES. INT. 2013, 2013, pages 1 - 5
  • - FENG, M ET AL.: "Functional and immunoreactive levels of IgG4 correlate with clinical responses during the maintenance phase of house dust mite immunotherapy", J. IMMUNOL., vol. 200, 2018, pages 3897 - 3904
  • - SHAMJI, M. H. ET AL.: "Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy", ALLERGY EUR. J. ALLERGY CLIN. IMMUNOL., vol. 67, 2012, pages 217 - 226, XP055847506
  • - NEERVEN, R. J. ET AL.: "Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-lgE-facilitated allergen presentation", J. IMMUNOL., vol. 163, 1999, pages 2944 - 52
  • - SCHMITZ, N. ET AL.: "Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: A novel therapy for cat allergy", J. EXP. MED., vol. 206, 2009, pages 1941 - 1955
  • - VAN RIJT, L. S. ET AL.: "Birch pollen immunotherapy in mice: Inhibition of Th2 inflammation is not sufficient to decrease airway hyper-reactivity", INT. ARCH. ALLERGY IMMUNOL., vol. 165, 2014, pages 128 - 139
  • - JENSEN-JAROLIM, E.: "Aluminium in allergies and allergen immunotherapy", WORLD ALLERGY ORGAN. J., vol. 8, 2015, pages 1 - 6
  • - AGLAS, L. ET AL.: "Context matters: TH2 polarization resulting from pollen composition and not from protein-intrinsic allergenicity", J. ALLERGY CLIN. IMMUNOL., vol. 142, 2018, pages 984 - 987
  • - PFAAR, O. ET AL.: "Perspectives in allergen immunotherapy: 2019 and beyond", ALLERGY EUR. J. ALLERGY CLIN. IMMUNOL, vol. 74, 2019, pages 3 - 25, XP071463134, DOI: 10.1111/all.14077
  • - JANKOVIC, D.KUGLER, D. G.SHER, A.: "IL-10 production by CD4+ effector T cells: A mechanism for self-regulation", MUCOSAL IMMUNOL., vol. 3, 2010, pages 239 - 246
  • - VAN RIJT, L. S. ET AL.: "Persistent activation of dendritic cells after resolution of allergic airway inflammation breaks tolerance to inhaled allergens in mice", AM. J. RESPIR. CRIT. CARE MED., vol. 184, 2011, pages 303 - 311
  • - MAYORGA CRISTOBALINA ET AL: "Role of nanostructures in allergy: Diagnostics, treatments and safety", vol. 76, no. 11, 9 March 2021 (2021-03-09), United Kingdom, pages 3292 - 3306, XP093002759, ISSN: 0105-4538, Retrieved from the Internet <URL:https://onlinelibrary.wiley.com/doi/full-xml/10.1111/all.14764> DOI: 10.1111/all.14764
  • - LEE SONGYI ET AL: "Nano theranostics platforms that utilize proteins", COORDINATION CHEMISTRY REVIEWS, ELSEVIER SCIENCE, AMSTERDAM, NL, vol. 412, 28 February 2020 (2020-02-28), XP086100097, ISSN: 0010-8545, [retrieved on 20200228], DOI: 10.1016/J.CCR.2020.213258

Cited patents 13

WO9632406A1 US4812405A US4818700A US4929555A US5736383A US5955349A US5888768A US6258559B1 US6852834B2 US4708871A US9388225B2 WO2013144412A1 WO2014059384A2